subject: Vitamin C and penicillin API is included in restricted development projects Development and Reform Commission - vitamin C, penicillin, bulk drugs - [print this page] Vitamin C and penicillin API is included in restricted development projects Development and Reform Commission - vitamin C, penicillin, bulk drugs -
"(" The List ") draft, in the pharmaceutical industry, Vitamin C And penicillin, which are Chinese large API Limits the development of sub-sectors were classified as class projects.
From the current industrial structure of China's API terms, vitamins and anti-inflammatory class of drugs is still raw in the international market, China has a "comparative advantage" of the sub-sectors, especially in vitamin C and penicillin production of APIs largest output, were all accounted for about 70% world market share, annual export earnings are over 100 million U.S. dollars.
"These two sub-sectors assigned to the restricted category, it is quite consistent with the current development of China's API industry status quo." Chinese Journal of Chemistry Pharmacy Yu Guanwen Industry Association senior adviser told reporters.
Look at the "catalog" put forth restrictions on the development of class projects, essentially a high energy consumption, high pollution and low added value industries. Vitamin C and penicillin API is also true, as are considered fermentation of industrial, in the past few years, these two types of APIs endless violations of environmental protection, bulk drug industry was designated 12 key environmental management industries.
"From the Energy Reduction point of view, does not fit to develop. "Four domestic manufacturers of penicillin API anti-medicine, general manager of Forest Types Lu also told reporters.
"Industry itself, there are self-limiting the need to present these two products are in excess supply and demand situation." Shuguan Wen said, "the phenomenon of productivity bye very serious, such as penicillin industrial salt, the global annual demand for about 5 million tons, while production capacity of Chinese enterprises are close to 100,000 tons. "Zheng-Hai Zhang said.
In serious excess capacity situation, the recent years, the frequent occurrence of these two sub-industry price war, foreign Anti-dumping Litigation. This period of low prices of the two products are quite different with little production costs, coupled with the yuan appreciation, lower export tax rebate rate, production costs, environmental costs and other factors, has been reduced to low value-added industries.
National Development and Reform Commission in the "directory" will be assigned to these two categories API limits the same time, the NDRC and Business Department on December 1 implementation of the "foreign Investment Industrial Guidance Catalogue (2007 Amendment) ", also the vitamins, penicillin, paracetamol and other bulk API ranks assigned to limit foreign investment.
"China in the leading position in several sub-sectors and, indeed, not necessary, and foreign joint venture Cooperation . "Health Net Pakistani researcher Yan Feng told reporters.
In fact, the past few years, in large areas of raw material medicine, little foreign investment figure, a few years ago BASF And the Northeast Pharmaceutical project on the cooperation of Vitamin last fall through, but two years ago DSM and North China Pharmaceutical on vitamins and Antibiotic Cooperation projects submitted after the NDRC and the Ministry of Commerce, after two years has not yet been approved.
Zheng-Hai Zhang said: "The foreign investment in the cooperation on the basis of raw material medicine, is equal to the high energy consumption, high pollution transfer to China, the products are exported to other countries. China's industrial structure upgrade and negative." In fact, the since 90 century, China's vitamin and penicillin drug raw materials come from behind, it takes over Switzerland, the United States, Italy and other European countries, the transfer of industries.
"Cooperation with foreign capital should be more focus on developing high-end products and the use of advanced production technology, such as the enzyme on the fermentation of green alternatives. More importantly, in the limit, while the bulk raw material medicine, can promote downstream enterprises to develop high value-added chain, steering Preparation Pharmaceutical Excipients , Intermediate And environmental technology research, development and cooperation with foreign investors come, these projects are encouraged. "Shuguan Wen said. I want to comment
